Showing 871-880 of 23043 results for "".
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
https://reachmd.com/programs/cme/asparaginase-based-treatment-young-adults-all/37193/Are you up to date on treatment strategies for young adults with acute lymphoblastic leukemia (ALL)? Evolving evidence and clinical guidelines now strongly support the use of asparaginase-based, pediatric-inspired regimens over traditional adult protocols for young adults with ALL. However, many patCase-Based Approach: Optimizing Cardio-Kidney-Metabolic Outcomes in Individuals With T2D & CKD
https://reachmd.com/programs/cme/case-based-approach-optimizing-cardio-kidney-metabolic-outcomes-in-individuals-with-t2d-ckd/29906/Case-Based Approach: Optimizing Cardio-Kidney-Metabolic Outcomes in Individuals With T2D & CKDConfronting Antisemitism in Medicine and Dermatology
https://modernaesthetics.com/ma-issues-index/march-april-2026-issue/confronting-antisemitism-in-medicine-and-dermatology/56632/Why rising hate demands action from physicians and practice leadersEstablishing Our Foundation of LGMD2I/R9
https://reachmd.com/programs/cme/establishing-our-foundation-of-lgmd2ir9/35588/Learn about LGMD2I/R9—genetics, diagnosis, treatment, clinical trials, and care gaps—in this expert-led, comprehensive educational video series.How to Identify & Manage Patients with Progressive-Fibrosing ILD
https://reachmd.com/programs/cme/how-to-identify-and-manage-patients-with-progressive-fibrosing-ild/10942/ILD diagnosis is complex and management can be tricky. Hear how to navigate this path and how the patient’s perspective can influence the care plan.Advances in the Management of Difficult-to-Treat Asthma
https://reachmd.com/programs/cme/advances-in-the-management-of-difficult-to-treat-asthma/10893/This multidisciplinary, virtual roundtable brings together clinicians and a patient to discuss clinical aspects of care in people with asthma.No Patient with CKD Left Behind! Emerging CKD Therapies in T1D
https://reachmd.com/programs/cme/no-patient-with-ckd-left-behind-emerging-ckd-therapies-in-t1d/36524/Gain insights in CKD screening practices, pathophysiology, and treatment from the results of the FINE-1 trial evaluating finerenone in patients with type 1 diabetes.Crossing Boundaries: CETP Inhibitors and the Next Frontier in Lipid Control
https://reachmd.com/programs/cme/crossing-boundaries-cetp-inhibitors-and-the-next-frontier-in-lipid-control/33025/Exploring CETP inhibition as the next breakthrough in lipid lowering, cardiologists highlight mechanisms, trials, and its role as a future CV therapy.Optimizing Outcomes: Evidence-Based Strategies for Treating Patients With Heart Failure With Mildly Reduced or Preserved Left Ventricular Ejection Fraction
https://reachmd.com/programs/cme/optimizing-outcomes-evidence-based-strategies-for-treating-patients-with-heart-failure-with-mildly-reduced-or-preserved-left-ventricular-ejection-fraction/29905/Optimizing Outcomes: Evidence-Based Strategies for Treating Patients With Heart Failure With Mildly Reduced or Preserved Left Ventricular Ejection FractionThoughts on Physician Advocacy and Payment Reform with AMA Past-President Andrew Gurman, MD
https://reachmd.com/programs/perspectives-ama/thoughts-physician-advocacy-payment-reform--ama-past-president-andrew-gurman-md/8183/Previously recorded in 2016 - For current information on MACRA, please visit reachmd.com/ama